Dr Reddy’s Laboratories enters into licensing agreement with Slayback Pharma EP News Bureau Aug 2, 2022 The partnership aims to obtain exclusive rights in the first-to-file ANDA for the private label version of Lumify in the US
Slayback Pharma announces investment of $50 million by The Everstone Group EP News Bureau Jan 6, 2020 The new capital will be used to expand and accelerate further Slayback’s pipeline of complex generic and specialty pharmaceutical…
Complex generics – An insight EP News Bureau Jul 5, 2019 Dr Girish Jain, Head- Global R&D, Slayback Pharma and a veteran in the field of pharma R&D gave a very informative session…
